share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Recursion Pharmaceuticals | 144:擬議出售證券
美股sec公告 ·  08/06 16:54
Moomoo AI 已提取核心訊息
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 08/06/2024, as per the latest filing. These shares, valued at approximately $78,083.44, were originally acquired on 09/01/2016 as founders shares and as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $694,221.07.
Recursion Pharmaceuticals, Inc. Director Borgeson Blake is set to sell 11,447 Class A shares of the company on 08/06/2024, as per the latest filing. These shares, valued at approximately $78,083.44, were originally acquired on 09/01/2016 as founders shares and as part of compensation from the issuer. This planned sale follows a series of transactions over the past three months, where a total of 77,289 shares were sold for gross proceeds of $694,221.07.
根據最新報告,Recursion Pharmaceuticals, Inc. 的董事Borgeson Blake將於2024年08月06日出售11,447股A類公司股票。這些股票價值約爲78,083.44美元,最初於2016年09月01日作爲創始人股份和向發行人獲得的補償股份獲得。此次計劃的出售是在過去三個月中進行的一系列交易之後進行的,這些交易總共賣出了77,289股股票,總交易額達到694,221.07美元。
根據最新報告,Recursion Pharmaceuticals, Inc. 的董事Borgeson Blake將於2024年08月06日出售11,447股A類公司股票。這些股票價值約爲78,083.44美元,最初於2016年09月01日作爲創始人股份和向發行人獲得的補償股份獲得。此次計劃的出售是在過去三個月中進行的一系列交易之後進行的,這些交易總共賣出了77,289股股票,總交易額達到694,221.07美元。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息